TER: AI Demand Broadens. The $336M Cash Test.

The 60-second read

Five things to know

1. Demand has broadened. Memory, interconnect, storage and robotics support the AI story.
2. Cash needs proof. Inventory and prepayments absorbed $336.3M in the quarter.
3. Ownership matters. Consolidated profit exceeds the amount attributable to common shareholders.
4. Guidance remains strong. Q4 sales midpoint is $1.300B, with adjusted EPS midpoint $2.10.
5. Price carries a hurdle. $313.24 implies $1.727B of equity cash at a 3.5% yield.

Three scenarios, one probability-weighted number

Analyst scenarios; probabilities sum to 100%.

Signposts: what would change our mind

Dates are analyst monitoring deadlines, not announced company event dates. Read actual filings; thresholds do not replace judgment.

The tape — broader demand, a cash conversion test

Our call is HOLD, with conviction of two out of five and High uncertainty. The October 28 closing reference is $313.24, down 3.23% from the previous $323.68 close. These are the saved provider figures, not a live promise about the next trade. Teradyne has delivered a much larger earnings base, yet the price still assumes that the current AI investment cycle converts into substantial recurring shareholder cash. That conversion is the central question in this quarter’s report.

Three independent equity valuation routes produce approximately $200, $254 and $266 per share. Their arithmetic mean is $239.97, rounded to a $240 analyst fair-value anchor. Our scenario-weighted value is $257.50, above the anchor because the bullish outcome is asymmetric, but both sit below the reference price. A conditional $192 entry checkpoint would provide a twenty-percent cushion to the anchor only if business evidence remains intact. A lower price caused by a permanent demand loss would require a new valuation, not automatic buying.

Teradyne designs automated test equipment and robotics systems. Its customers use test equipment to validate semiconductor and electronics performance; its collaborative and mobile robots support manufacturing and warehouse processes. This quarter’s issuer narrative broadens the AI opportunity beyond compute into memory, hard-disk-drive test, high-speed interconnect and robotics. Broader applications can improve resilience, but several still depend on the same AI capital-spending cycle. A longer product list is not the same thing as independent demand streams.

The Q3 release was issued October 27 at 3:30 p.m. Chicago time, after the US cash-market close. The quarter ended September 27. Its SEC 8-K followed on October 28; that acceptance clock is distinct from the release and the earnings call. Prior Q2 coverage focused on a 104% revenue jump, a guidance beat and an erased trading gap. The current report instead examines the new inventory and prepayment commitment, reported profit ownership and the cash hurdle embedded in the price.

The print — a strong quarter with a narrower beat

Revenue was $1.306 billion, up 69.78% from $769.2 million a year earlier. GAAP net income attributable to Teradyne reached $342.4 million, or $2.17 per diluted share. Adjusted attributable net income was $359.9 million and adjusted diluted EPS was $2.29. The provider’s retained consensus was $1.268 billion of revenue and $2.09 adjusted EPS, implying beats of 3.01% and 9.57%. This is a dated comparison retrieved after the release, not an independently captured final pre-release consensus poll.

The result also exceeded management’s previous upper guidance limits of $1.300 billion sales and $2.15 adjusted EPS. The revenue excess was only about $6 million, while adjusted EPS exceeded the upper end by fourteen cents. Both observations can be true: the earnings surprise was meaningful, and the sales result was near the top of a range that had already anticipated strong AI demand. The appropriate valuation question is the durability of that earnings base, not simply whether the headline says beat.

Gross profit was $771.3 million, or 59.06% of sales, and GAAP operating profit was $402.0 million, or 30.78%. The adjusted operating margin was 31.6%. These are attractive economics, but adjusted operating margin was 33.7% in Q2 and 37.5% in Q1. The new quarter’s investment and business mix therefore matter. We do not label every sequential margin change structural deterioration, yet we also avoid capitalizing the first quarter’s peak margin as a permanent rate.

Fourth-quarter revenue guidance is $1.250–$1.350 billion, with GAAP EPS of $1.88–$2.18 and adjusted EPS of $1.95–$2.25. The sales midpoint is 2.41% above the saved provider estimate for the next quarter; adjusted EPS midpoint of $2.10 compares with $2.04. These modest differences are sensitive to the provider’s update timing. The release supplies no separate full-year revenue, cash-flow or organic-growth forecast, so the packet does not invent one.

Segments — breadth still needs an ownership adjustment

Semiconductor Test produced approximately $1.072 billion of revenue, Product Test $138 million and Robotics $96 million. These issuer figures are rounded to whole millions and sum to $1.306 billion, slightly above the precise consolidated total because of rounding. Semiconductor Test remains roughly eighty-two percent of sales. The business is broader than a single chip-testing application, but consolidated results remain heavily dependent on semiconductor capital investment and program timing.

Product Test sales grew roughly 57% from the prior-year rounded $88 million, while Robotics grew 28% from $75 million. Semiconductor Test rose roughly 77% from $606 million. The release attributes record Memory and Integrated Systems Test revenue to AI-related demand and says Robotics achieved profitability and its highest third-quarter revenue. It does not provide a Q3 segment profit table, an organic acquisition bridge or an exact Robotics profit number. Those omissions limit how precisely we can allocate consolidated earnings growth.

The June 28 10-Q explains an important comparability issue. On April 8, Teradyne acquired a controlling seventy-five-percent interest in the MultiLane Test Products venture for approximately $157.8 million. The venture is consolidated within Product Test, so consolidated sales include the controlled business while a portion of its earnings belongs to other owners. At June, management did not separately disclose standalone revenue or profit because the acquisition was not material to the consolidated statements. That is not permission to call all Product Test growth organic.

Quantifi Photonics, acquired in May 2025, adds another historical comparison consideration. The company also owns ten percent of Technoprobe, accounted for under the equity method. The latter contributes an equity-earnings line rather than consolidated sales. These structures are different: controlled subsidiary sales, noncontrolling earnings deductions and equity-method affiliate profit cannot be combined into one casual acquisition adjustment. We would look for a cleaner organic bridge and segment profitability detail in the next filing before assigning a larger diversification premium.

Profit quality — distinguish parent earnings from the group

The income statement begins with $402.0 million of operating income and $2.3 million of interest and other income. That produces $404.3 million before income taxes. The $59.8 million tax provision leaves $344.5 million before equity in affiliate earnings. Adding $3.3 million of affiliate earnings gives $347.7 million consolidated net income. Subtracting $5.3 million attributable to noncontrolling interests produces the $342.4 million belonging to Teradyne shareholders. Our EPS and valuation denominators use that parent economic claim.

This distinction is small enough to be overlooked and large enough to matter when growth comes through partially owned businesses. The saved market-data income statement places affiliate earnings in its pretax aggregation, showing $407.6 million before tax. The issuer’s actual presentation shows $404.3 million before income taxes and adds affiliate earnings later. We use the issuer’s order and definitions. A provider normalization is not evidence that the filing’s tax rate or parent earnings bridge has changed.

Adjusted operating profit adds back acquired intangible amortization, restructuring and ERP implementation costs. The issuer’s rounded reconciliation moves from $402.0 million to $412.9 million; individual rounded add-backs total approximately $11.0 million. Adjusted attributable net income also reverses amortization on the equity-method investment and includes tax, pension and noncontrolling-interest adjustments. The result is $359.9 million. Because several inputs are rounded, summing the printed tenths can differ slightly from the reported endpoint.

Most of the quarter’s earnings are therefore already visible under GAAP. Nevertheless, an expense excluded from an adjusted metric can still represent an economic cost. ERP projects require spending, acquired technology wears out, and restructuring can recur. Our valuation does not simply apply a premium multiple to every adjusted dollar without checking reinvestment. Conversely, treating all amortization as a current cash outflow would also distort the cash statement. The sensible approach is to reconcile the measures and evaluate each exclusion in context.

Cash — the $336 million working-capital test

Quarterly operating cash flow was $313.6 million. Subtracting $86.3 million of capital expenditures gives $227.3 million of simple free cash flow, or 66.38% of attributable GAAP earnings. This definition is our straightforward operating-cash-minus-capex calculation; it is not the company’s adjusted EPS and does not deduct acquisitions, investments, dividends or repurchases. Last year’s comparable free cash flow was only $2.4 million, so the year-over-year improvement is real even though conversion remains below reported profit.

The largest new operating commitment is the cash absorbed by inventory and prepayments. The cash-flow statement shows $170.9 million used by inventory and $165.3 million used by prepayments and other assets, a combined $336.3 million. Accounts payable and other liabilities supplied $225.8 million, partly offsetting those uses. Customer advances added another $13.2 million. These are working-capital movements, not independent profit sources, and the combined inventory/prepayment figure should not be mistaken for a loss or a future write-off forecast.

At the balance-sheet level, inventory reached $575.0 million from $403.3 million in June, an increase of 42.57% in one quarter. Prepayments increased to $613.7 million from $468.2 million. Management may be positioning supply for expected demand, but a larger commitment also increases exposure to delayed customer ramps, changing configurations and excess stock. The quarter’s excess-and-obsolete inventory provision was $10.9 million, compared with $3.6 million in Q2. That provision is a risk indicator, not proof that all new inventory is impaired.

Year-to-date operating cash reached $1.048 billion and simple free cash flow $806.1 million. This exceeds the full-year 2025 $450.4 million free-cash total, showing the larger business’s cash potential. It also provides context for Q3: a single quarter need not convert every dollar of profit if cash timing reverses later. Our test is whether inventory and prepayments support profitable deliveries and whether payable support unwinds without eroding owner cash. We would not remove working-capital investment from the cash statement merely to make conversion look smoother.

Balance sheet — liquidity is adequate, not free valuation upside

Cash and cash equivalents were $460.7 million. Current and long-term marketable securities add $164.1 million, giving $624.9 million of liquid financial assets. There were no short-term borrowings on the September balance sheet. The August credit agreement provides a five-year, one-billion-dollar secured revolving facility, but borrowing capacity is not cash already owned. Lease obligations, retirement liabilities, taxes and working-capital commitments still matter even when the financial-debt line is zero.

Total assets reached $5.449 billion, including $1.111 billion of receivables, $575.0 million of inventory and $613.7 million of prepayments. Total liabilities were $1.712 billion, redeemable noncontrolling interests $49.1 million and parent shareholders’ equity $3.688 billion. The redeemable interest should not disappear when calculating residual common-holder value. Likewise, the $518.6 million equity-method investment is an asset carrying value, not automatically a cash premium that can be added to a multiple already capitalizing affiliate earnings.

The current statements compare December 2025 assets with $4.184 billion, while the original year-end release showed $4.170 billion. Receivables differ by the same $13.346 million. We retain the original annual series and use the current comparative when describing current year-to-date balance changes. The reviewed materials do not establish a sufficiently explicit cause for that difference, so we do not assign it to acquisition accounting or label it an error without evidence. This is a bounded comparability disclosure, not an unresolved current filing exclusion.

The balance sheet does not presently force an emergency financing thesis. Our caution is instead about the amount of capital needed to support a larger operating platform. A strong liquidity position can protect investment through a downturn; it does not make every inventory or acquisition dollar productive. The useful next evidence is receivable collection, delivery of prepaid components and returns from controlled and affiliated businesses. These measures reveal whether the enlarged asset base translates into cash belonging to common shareholders.

Valuation — three ways to price the cash burden

The earnings route assumes sustainable diluted EPS of $9.50 and a twenty-eight-times multiple, producing $266 per share. The EPS assumption is broadly near the current nine-month adjusted EPS plus Q4 guidance arithmetic, but it is an analyst normalization rather than a company annual forecast. Adding quarterly EPS is only an approximation because weighted share counts change. Twenty-eight times already allows a substantial quality and growth premium; it is not a distressed-cycle multiple.

The owner-cash route assumes $1.400 billion of sustainable annual cash after taxes, reinvestment and financing costs. Capitalizing it at a 3.5% equity cash yield and dividing by 157.502 million diluted shares gives $253.97. This is a demanding assumption: it exceeds the $806.1 million generated in the first nine months, and it requires more than simply repeating Q3. The cash stream includes the economic affiliate contribution and a prudent allowance for the resources needed to maintain the platform. We do not add the affiliate carrying value a second time.

The discounted-cash route uses five annual equity cash flows of $1.2, $1.5, $1.85, $2.2 and $2.5 billion. We discount at ten percent and use 3.5% perpetual growth. Explicit-period present value is $6.775 billion and terminal present value $24.717 billion. Their sum divided by 157.502 million shares gives $199.95. Because these are equity cash flows after financing costs, the result is already common-equity value; no mechanical second subtraction of debt or addition of operating cash is made.

The three values average $239.97, supporting our rounded $240 anchor and a $200–$266 method range. They are not equally reliable predictions of a future quote. The DCF is especially sensitive to cash growth and terminal assumptions; the earnings multiple can conceal reinvestment needs; and the cash-yield route depends on a normalized cash level not yet demonstrated for a full year. Using all three makes those disagreements visible. The valuation conclusion is that a strong operating story still needs either more cash evidence or a more forgiving entry price.

Wall Street — optimistic targets, dated inputs

The saved analyst aggregation reports nineteen buys, twelve holds and no sells, with a Buy consensus. Its target mean is $471.71, median $465 and range $397–$550. Those values are well above our $240 analyst anchor. The gap does not prove that either approach is correct. It identifies different assumptions about test demand, future margins, cash conversion and the valuation premium investors will accept.

The named target records returned with this dataset are dated July and June, not fresh Q3 research updates. Morgan Stanley’s July 30 target is $397, Baird’s July 30 target $420, Evercore ISI’s July 30 target $420 and Goldman Sachs’s July 28 record $465. These are provider records of broker actions, not direct access to the full research models. We do not infer detailed broker reasoning from a target headline or present those dates as new reactions to the October report.

This timing distinction is important because the quote has changed and the business has reported another quarter. An old optimistic target can remain useful context without being a current valuation endorsement. Likewise, a mean price target is not a discounted cash-flow calculation and should not be averaged mechanically with our methods. Our report keeps the Wall Street comparison visible while maintaining a separate, source-backed financial model and explicit assumptions.

The right way to resolve disagreement is with evidence. If Teradyne sustains the projected 2027 earnings, converts inventory into cash without repeated financing support, and broadens profitable demand across businesses, a higher value becomes easier to defend. If revenue remains strong but cash and margins disappoint, the target gap can close through lower estimates rather than a higher share price. Both paths are plausible, which supports High uncertainty rather than false precision.

Capital allocation — reinvestment comes before distributions

Q3 simple free cash of $227.3 million covered $99.3 million of common-share repurchases and $20.3 million of dividends. Those two distributions totaled $119.6 million, leaving approximately $107.7 million before business investments and other financing items. Cash still increased by $111.2 million during the quarter. That is evidence of useful cash generation, but the cash increase also reflects option and employee-plan proceeds, securities transactions and other items; it is not identical to residual free cash after shareholder returns.

Year-to-date capital expenditures were $241.8 million, acquisitions consumed $165.6 million net of acquired cash, and business investments used $20.9 million. The company repaid a net $200 million of revolver borrowings over the nine months. These competing uses show why valuation should be based on cash after the investment needed to sustain growth. Acquisition spending is excluded from simple free cash flow but still consumes capital; recurring deal dependence would warrant a separate economic charge.

Stock compensation was $21.7 million in Q3 and $63.6 million year to date. It is a noncash add-back in operating cash flow, yet common shareholders bear dilution unless repurchases offset it economically. The current diluted weighted-average share count is 157.502 million, versus 159.097 million a year earlier. We use the diluted denominator consistently in valuation rather than switching to the lower point-in-time basic share count to improve the per-share answer. Net settlement cash and option proceeds are disclosed separately from the expense.

The historical table shows that revenue grew from $2.676 billion in 2023 to $3.190 billion in 2025, while free cash moved from $425.6 million to $450.4 million. The new nine-month 2026 cash level is materially stronger than those annual periods. The bull case is therefore not imaginary. Its burden is to prove that the step-up survives inventory normalization, continued R&D and a less favorable demand mix. We focus on that next conversion test rather than recycling the previous episode’s first-half buyback-cut headline.

Risks and decision rules — test the thesis, not the headline

The bullish case is that greater test complexity and a wider set of AI-linked applications generate sustained equipment demand. Memory, high-speed connections, storage and robotics could extend growth beyond a single compute program. Higher volumes can support R&D and operating leverage, while the installed base creates future opportunities. If cash conversion follows that growth, current valuation concerns can diminish through a larger denominator rather than a lower price.

The bearish case is that customer spending and delivery schedules remain cyclical. Inventory and supplier commitments are made before the ultimate quality of demand is fully known. A program delay or architecture change can leave capacity and parts underused, pressuring margins and cash together. Export controls and tariffs add uncertainty to a business with substantial Asian customer-site exposure. The latest filed June quarter showed Taiwan at forty percent of revenue and Korea at twenty percent; these are dated customer-site figures, not an invented Q3 geography mix.

Acquisitions add execution and accounting complexity. The MLTP venture’s minority interest means not all consolidated economic gains belong to Teradyne holders. Technoprobe’s equity-method earnings can fluctuate without matching cash distributions. Robotics profitability is encouraging, but the current release does not quantify its margin. None of these ordinary transactions excludes the listed parent from coverage; they are reasons to demand disciplined analysis and measured expectations.

Our base case values the shares at $240; a $170 bear case uses $8.50 normalized earnings at twenty times, while a $380 bull case uses $11.875 at thirty-two times. At twenty-five, fifty and twenty-five percent probabilities, weighted value is $257.50. These are analyst scenarios rather than price forecasts. We will monitor Q4 revenue, margin, free cash, inventory conversion and segment disclosure at dated checkpoints. A monitoring deadline is not a fabricated company event, and a threshold is not a substitute for reading the next actual filing.

Expectations — what $313 already asks the business to deliver

At $313.24 and 157.502 million diluted shares, the illustrative diluted equity value is approximately $49.34 billion. At the 3.5% cash yield used in our owner-cash route, that price requires about $1.727 billion of sustainable annual equity cash. This is a reverse valuation, not management guidance. It exceeds our $1.4 billion normalized assumption by roughly twenty-three percent and provides a concrete way to judge whether current operating progress is enough.

The same price is about thirty-three times our $9.50 normalized EPS. A higher multiple can be justified if test intensity, competitive position and cash conversion all improve, but the investor then depends on continued premium pricing as well as earnings growth. A multiple of thirty-three is not guaranteed merely because the customer uses AI. Product cycles, competitor offerings, export restrictions and customer concentration can change the stream’s risk even while the total AI market expands.

The saved provider consensus for 2027 averages $6.280 billion of revenue and $11.78 EPS, with eleven EPS contributors and a range of approximately $9.26–$13.38. Those estimates imply considerable operating growth beyond Q4’s run rate. They are third-party forecasts, not contractual orders or company promises. Our normalized EPS assumption sits below the mean because cash demands, investment and margin mix remain unresolved. If the company demonstrates the higher earnings with strong owner-cash conversion, the valuation should be revisited.

Sensitivity analysis is more useful than arguing over a single target. At $8 of sustainable EPS and twenty-four times earnings, value is $192. At $10 and thirty times, it is $300. At $12 and thirty-four times, it is $408. Each cell requires both an earnings outcome and a willingness to pay the selected multiple. The table is not a probability distribution; it reveals the assumptions a buyer must own. Our scenario model separately assigns probabilities and should not be confused with the arithmetic sensitivity grid.

Appendix — reproducible figures and source discipline

The nine-quarter table is built from each quarter’s actual SEC-filed issuer release. It retains original reported amounts rather than silently smoothing them into a provider-normalized series. Small one-thousand-dollar differences can arise when annual or year-to-date sums are converted into quarterly provider data. We keep the original release for the quarter and label current comparative changes when they affect interpretation. Missing segment disclosure is left missing, not filled with a convenient estimate.

Two provider errors were material enough to correct explicitly. Several older inventory fields included amounts beyond the filed inventory line: for example, Q3 2024 showed $737.0 million in the provider field versus $297.3 million in the issuer statement. The provider’s 2025 diluted EPS of $3.48 was the filing’s basic EPS; the actual diluted amount was $3.47. Our tables use the primary figures. The market feed remains useful for dated prices and consensus, but it is not allowed to override the financial statements.

The current SEC 8-K provides Q3 income, balance-sheet and cash-flow statements plus GAAP-to-non-GAAP reconciliations. The latest available 10-Q covers June 28, so its effective-controls conclusion is correctly dated to June. The current Q3 10-Q was not available in the verified submissions. Historical 2018 exchange-transfer and 2025 bylaw filings were reviewed as resolved or ordinary events for the continuing Nasdaq common security. Age alone was never treated as proof of resolution.

Every valuation input is an analyst assumption unless specifically labeled as issuer guidance or provider consensus. Dollar amounts in the history tables are millions; EPS and valuation figures are dollars per share. Simple free cash flow means operating cash minus capital expenditures. The packet is the financial source of the accompanying presentation and Short, so call, conviction, uncertainty and fair value remain consistent across formats. New information can change the conclusion; the saved inputs make that change reviewable.